面向肿瘤学领域数字患者导航工具的用户中心设计：范围综述
User-Centered Design for Digital Patient-Navigation Tools in Oncology: Scoping Review
浏览论文内容
中文总结 AI 辅助
本范围综述遵循规范检索分析36项研究，发现UCD/HCD可提升癌症数字导航工具可用性但应用不足，明确其应用现状与改进方向。
中文摘要 AI 辅助
癌症患者导航计划可改善医疗服务的可及性与连续性，但其数字化转型常受限于可用性差和使用率不足的问题。应用用户中心设计（UCD）与以人为中心设计（HCD）原则或可缩小这一差距，但目前尚不明确此类设计方法在肿瘤导航工具中的应用及评估程度。本范围综述旨在明确UCD/HCD原则在癌症患者导航用数字健康工具开发与实施中的现有应用及未来应用方向。本范围综述遵循PRISMA-ScR（系统评价与荟萃分析优先报告条目扩展至范围综述的规范）及Joanna Briggs Institute指南开展，检索了7个数据库（PubMed/MEDLINE、Scopus、IEEE Xplore、Web of Science、Embase、ACM Digital Library、CINAHL）中2015年1月至2025年7月发表的英文文献。纳入标准为报告与癌症导航相关的数字或移动健康干预的原创同行评审研究，且记录至少1项UCD/HCD活动。两名评审员独立筛选记录，并绘制关于背景、目标用户、功能、工具模态、设计阶段、方法及结果的数据。研究结果经描述性和主题性综合后，共36项研究符合纳入标准，结果分为4个领域：研究特征、导航功能与数字模态、设计流程与方法、UCD/HCD应用。迭代原型设计与可用性测试是最常用的方法，而参与式设计与实施评估的应用不足。UCD/HCD方法可提升癌症导航数字工具的可用性与患者相关性，但其在癌症类型、地区及功能方面的应用仍存在局限性。
英文摘要
Navigation programs for patients with cancer improve access and continuity of care, yet their digital transformation is often limited by poor usability and inadequate uptake. Applying user-centered and human-centered design (UCD/HCD) principles may close this gap, but the extent to which such design methods are used and evaluated in oncology navigation tools remains unclear. This scoping review identifies how UCD/HCD principles have been, and should be, applied in developing and implementing digital health tools for navigation for patients with cancer. A scoping review was conducted following PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) and Joanna Briggs Institute guidance. A total of 7 databases (PubMed/MEDLINE, Scopus, IEEE Xplore, Web of Science, Embase, ACM Digital Library, and CINAHL) were searched for English-language articles published between January 2015 and July 2025. Eligible studies reported original, peer-reviewed research on digital or mobile health interventions linked to cancer navigation and documented at least 1 UCD/HCD activity. Two reviewers independently screened records and charted data on context, target users, functions, tool modality, design phase, methods, and outcomes. Findings were synthesized descriptively and thematically. A total of 36 studies met the inclusion criteria. Findings were organized into 4 domains: study characteristics, navigation functions and digital modalities, design processes and methods, and UCD/HCD application. Iterative prototyping and usability testing were the most common, while participatory design and implementation evaluation were underused. UCD/HCD approaches enhance usability and patient relevance of digital cancer navigation tools. However, their application remains limited across cancer types, regions, and functions.
